Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Liminatus Pharma Inc (NASDAQ: LIMN) was $0.72 for the day, down -31.54% from the previous closing price of $1.05. In other words, the price has decreased by -$31.54 from its previous closing price. On the day, 1.85 million shares were traded. LIMN stock price reached its highest trading level at $0.8571 during the session, while it also had its lowest trading level at $0.614.
Ratios:
Our analysis of LIMN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.42 and its Current Ratio is at 0.42.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIMN now has a Market Capitalization of 19454058 and an Enterprise Value of 20172056.
Stock Price History:
The Beta on a monthly basis for LIMN is 0.46, which has changed by -0.9105722 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, LIMN has reached a high of $33.66, while it has fallen to a 52-week low of $1.02. The 50-Day Moving Average of the stock is -47.29%, while the 200-Day Moving Average is calculated to be -89.66%.
Shares Statistics:
LIMN traded an average of 1.28M shares per day over the past three months and 345790 shares per day over the past ten days. A total of 27.06M shares are outstanding, with a floating share count of 5.56M. Insiders hold about 79.47% of the company’s shares, while institutions hold 1.34% stake in the company. Shares short for LIMN as of 1761868800 were 378072 with a Short Ratio of 0.30, compared to 1759190400 on 395921.
